The global plasma-derived medicine market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the market is the increasing incidence of rare and chronic diseases. According to the Orphanet database, around 263-446 million persons are affected with rare and chronic diseases at any given point of time globally. This is expected the fuel the demand for the market during the forecast period.

Plasma contains various ingredients such as nutrients, enzymes, hormones, and proteins. These properties of plasma make it a viable option for manufacturing life-saving proteins use to treat chronic and rare diseases. The molecules like albumin, FVII, and IVIG are used for the preparation of plasma-derived drugs for the treatment of diseases. There has been increasing consumption of albumin globally. The increasing number of albumin use in hospitals is expected to grow the demand of the market during forecast periods. Some of the key players in the global plasma-derived medicine market include Grifols, S.A., Octa Pharma, Antaris Pharma, CSL Limited, and many others.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By Product type

o By End-User

• Regions Covered 

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape - Grifols, S.A., Octa Pharma, Antaris Pharma, CSL Limited, and many others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Plasma-Derived Medicine Market by Segments

• By Product type

o Immunoglobulin

o Albumins

o Coagulation Factor

o Other

• By End-User  

o Hospital

o Clinics

o Other

Global Plasma-Derived Medicine Market by Regions